Agile Therapeutics Ownership 2024 | Who Owns Agile Therapeutics Now?
Institutional Ownership
0.00%
Insider Ownership
9.70%
Retail Ownership
90.30%
Institutional Holders
1.00
Agile Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -10 | -100.00% | - | Mar 31, 2024 |
Agile Therapeutics's largest institutional shareholder is CORNERSTONE PLANNING GROUP LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -10 | -100.00% | - | Mar 31, 2024 |
The largest Agile Therapeutics shareholder by % of total assets is CORNERSTONE PLANNING GROUP LLC. The company owns 0.00 shares of Agile Therapeutics (AGRX), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -10 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Agile Therapeutics's largest institutional buyer is CORNERSTONE PLANNING GROUP LLC. The company purchased -10.00 stocks of AGRX, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -10 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Agile Therapeutics's biggest institutional seller is CORNERSTONE PLANNING GROUP LLC. The company sold -10.00 shares of AGRX, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -10 | -100.00% | - | Mar 31, 2024 |
Agile Therapeutics's largest sold out institutional shareholder by shares sold is CORNERSTONE PLANNING GROUP LLC, sold -10.00 shares, valued at -, as of undefined.
Agile Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
ROYCE MICRO-CAP TRUST, INC. | 0.19% | 90,000 | - | - | Mar 31, 2024 |
NEEDHAM FUNDS INC | 0.17% | 350,000 | - | - | Mar 31, 2024 |
JOHN HANCOCK INVESTMENT TRUST | 0.02% | 1,815,895 | - | - | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 12,045 | - | - | Mar 31, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.02% | 114,870 | - | - | Mar 31, 2024 |
VANGUARD QUANTITATIVE FUNDS | 0.02% | 73,421 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.01% | 3,755,385 | - | - | Mar 31, 2024 |
NEXPOINT FUNDS I | 0.01% | 25,000 | - | - | Dec 31, 2023 |
FIDELITY CONCORD STREET TRUST | 0.00% | 630,921 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 70,357 | - | - | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 5,999 | - | - | Mar 31, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 40,600 | - | - | Feb 29, 2024 |
Principal Exchange-Traded Funds | 0.00% | 17,409 | - | - | Mar 31, 2024 |
RBB FUND, INC. | 0.00% | 126,000 | - | - | Feb 29, 2024 |
TIAA-CREF LIFE FUNDS | 0.00% | 3,534 | - | - | Mar 31, 2024 |
FLEXSHARES TRUST | 0.00% | 101,904 | - | - | Jan 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 237,651 | - | - | Feb 29, 2024 |
SunAmerica Specialty Series | 0.00% | 560 | - | - | Apr 30, 2021 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 32,073 | - | - | Mar 31, 2024 |
GPS Funds I | 0.00% | 4,563 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 31,320 | - | - | Feb 29, 2024 |
THRIVENT SERIES FUND INC | 0.00% | 54,404 | - | - | Mar 28, 2024 |
NORTHERN FUNDS | 0.00% | 38,788 | - | - | Mar 28, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,623 | - | - | Mar 31, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 12,200 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 76,860 | - | - | Mar 31, 2024 |
THRIVENT MUTUAL FUNDS | 0.00% | 14,740 | - | - | Mar 28, 2024 |
PGIM ETF TRUST | 0.00% | 8,549 | - | - | Feb 29, 2024 |
ProFunds | 0.00% | 1,474 | - | - | Mar 31, 2024 |
FIDELITY SALEM STREET TRUST | 0.00% | 489,308 | - | - | Mar 31, 2024 |
VALIC Co I | 0.00% | 32,235 | - | - | Feb 29, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 220,972 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 40,954 | - | - | Mar 31, 2024 |
PENN SERIES FUNDS INC | 0.00% | 2,700 | - | - | Mar 28, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 11,745 | - | - | Mar 31, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 10,243 | - | - | Jan 31, 2024 |
Goldman Sachs ETF Trust | 0.00% | 7,440 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 15,531 | 1,752 | 12.72% | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 14,055 | - | - | Jan 31, 2024 |
TIAA-CREF FUNDS | 0.00% | 179,791 | - | - | Mar 31, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 53,814 | - | - | Mar 31, 2024 |
VANGUARD WELLINGTON FUND | 0.00% | 17,989 | - | - | Feb 29, 2024 |
NEEDHAM FUNDS INC | 0.00% | 88 | -4,661 | -98.15% | Mar 31, 2024 |
NEEDHAM FUNDS INC | 0.00% | 88 | - | - | Mar 31, 2024 |
Brighthouse Funds Trust II | 0.00% | 33,678 | - | - | Mar 31, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,643 | - | - | Feb 29, 2024 |
Tidal Trust II | 0.00% | 762 | - | - | Jan 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 58,600 | - | - | Mar 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 7,345 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 245,923 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 14,492 | - | - | Mar 31, 2024 |
VANGUARD QUANTITATIVE FUNDS | 0.00% | 48 | - | - | Mar 31, 2024 |
PACIFIC SELECT FUND | 0.00% | 35,200 | - | - | Mar 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 8,266 | - | - | Dec 31, 2023 |
Bridge Builder Trust | 0.00% | 26,495 | - | - | Mar 31, 2024 |
Dimensional ETF Trust | 0.00% | 1,832 | - | - | Jan 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 5,254 | - | - | Mar 31, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 14,219 | - | - | Feb 29, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 8,972 | - | - | Mar 31, 2024 |
BLACKROCK FUNDS | 0.00% | 8,092 | - | - | Mar 28, 2024 |
iSHARES TRUST | 0.00% | 14,748 | - | - | Mar 31, 2024 |
John Hancock Funds II | 0.00% | 11,529 | - | - | Feb 29, 2024 |
SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 16,200 | - | - | Feb 29, 2024 |
Advisors' Inner Circle Fund III | 0.00% | 46 | - | - | Jan 31, 2024 |
Agile Therapeutics's largest mutual fund holder by % of total assets is "ROYCE MICRO-CAP TRUST, INC.", owning 90.00K shares, compromising 0.19% of its total assets.
Agile Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 23 | 1 | - |
31 Mar, 22 | 35 | -25.53% |
31 Dec, 21 | 47 | -12.96% |
30 Sep, 21 | 54 | -25.00% |
30 Jun, 21 | 72 | -10.00% |
31 Mar, 21 | 80 | -5.88% |
31 Dec, 20 | 85 | -1.16% |
30 Sep, 20 | 86 | 1.18% |
30 Jun, 20 | 85 | 21.43% |
31 Mar, 20 | 70 | 32.08% |
31 Dec, 19 | 53 | 55.88% |
30 Sep, 19 | 34 | 25.93% |
30 Jun, 19 | 27 | -3.57% |
31 Mar, 19 | 28 | 3.70% |
31 Dec, 18 | 27 | -3.57% |
30 Sep, 18 | 28 | -26.32% |
30 Jun, 18 | 38 | -20.83% |
31 Mar, 18 | 48 | -7.69% |
31 Dec, 17 | 52 | 6.12% |
30 Sep, 17 | 49 | 8.89% |
30 Jun, 17 | 45 | -13.46% |
31 Mar, 17 | 52 | -21.21% |
31 Dec, 16 | 66 | 13.79% |
30 Sep, 16 | 58 | 1.75% |
30 Jun, 16 | 57 | 7.55% |
31 Mar, 16 | 53 | 8.16% |
31 Dec, 15 | 49 | - |
30 Sep, 15 | 49 | -14.04% |
30 Jun, 15 | 57 | 46.15% |
31 Mar, 15 | 39 | 77.27% |
31 Dec, 14 | 22 | -4.35% |
30 Sep, 14 | 23 | 15.00% |
30 Jun, 14 | 20 | - |
As of 31 Dec 23, 1 institutions are holding Agile Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 23 | 10 | - |
31 Mar, 22 | 40,559,779 | 7.73% |
31 Dec, 21 | 37,651,153 | 18.45% |
30 Sep, 21 | 31,787,149 | -7.56% |
30 Jun, 21 | 34,385,876 | -10.17% |
31 Mar, 21 | 38,279,166 | -5.42% |
31 Dec, 20 | 40,473,649 | 4.16% |
30 Sep, 20 | 38,855,790 | 0.98% |
30 Jun, 20 | 38,478,555 | 16.51% |
31 Mar, 20 | 33,025,635 | 21.30% |
31 Dec, 19 | 27,226,133 | 13.28% |
30 Sep, 19 | 24,033,991 | 22.75% |
30 Jun, 19 | 19,579,798 | 5.62% |
31 Mar, 19 | 18,538,164 | 96.54% |
31 Dec, 18 | 9,432,299 | -34.68% |
30 Sep, 18 | 14,440,164 | -19.21% |
30 Jun, 18 | 17,872,674 | -27.60% |
31 Mar, 18 | 24,685,305 | 1.42% |
31 Dec, 17 | 24,338,567 | -2.35% |
30 Sep, 17 | 24,925,236 | 8.02% |
30 Jun, 17 | 23,075,553 | 0.52% |
31 Mar, 17 | 22,957,028 | -1.96% |
31 Dec, 16 | 23,414,959 | -2.47% |
30 Sep, 16 | 24,007,669 | -0.75% |
30 Jun, 16 | 24,188,418 | -0.81% |
31 Mar, 16 | 24,385,433 | 47.39% |
31 Dec, 15 | 16,544,352 | -22.79% |
30 Sep, 15 | 21,428,616 | 24.98% |
30 Jun, 15 | 17,145,049 | 3.51% |
31 Mar, 15 | 16,563,019 | 27.00% |
31 Dec, 14 | 13,041,523 | 68.86% |
30 Sep, 14 | 7,723,423 | -4.03% |
30 Jun, 14 | 8,047,341 | - |
Agile Therapeutics (AGRX) has 10.00 shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 23 | 0.00% | - |
31 Mar, 22 | 32.55% | 2.16% |
31 Dec, 21 | 38.79% | 3.62% |
30 Sep, 21 | 32.75% | 1.99% |
30 Jun, 21 | 40.61% | 1.99% |
31 Mar, 21 | 45.20% | 1.98% |
31 Dec, 20 | 47.79% | 2.27% |
30 Sep, 20 | 45.88% | 0.76% |
30 Jun, 20 | 77.84% | 1.74% |
31 Mar, 20 | 66.81% | 2.20% |
31 Dec, 19 | 55.08% | 2.33% |
30 Sep, 19 | 48.62% | 3.10% |
30 Jun, 19 | 39.61% | 2.82% |
31 Mar, 19 | 37.50% | 10.30% |
31 Dec, 18 | 19.08% | 2.24% |
30 Sep, 18 | 29.21% | 2.23% |
30 Jun, 18 | 36.16% | 1.45% |
31 Mar, 18 | 49.94% | 2.06% |
31 Dec, 17 | 49.24% | 1.94% |
30 Sep, 17 | 50.42% | 2.31% |
30 Jun, 17 | 46.68% | 2.16% |
31 Mar, 17 | 46.44% | 2.07% |
31 Dec, 16 | 47.37% | 2.01% |
30 Sep, 16 | 48.57% | 2.03% |
30 Jun, 16 | 48.93% | 2.01% |
31 Mar, 16 | 49.33% | 4.40% |
31 Dec, 15 | 33.47% | 1.78% |
30 Sep, 15 | 43.35% | 3.60% |
30 Jun, 15 | 34.68% | 3.09% |
31 Mar, 15 | 33.51% | 4.81% |
31 Dec, 14 | 26.38% | 10.81% |
30 Sep, 14 | 15.62% | 5.90% |
30 Jun, 14 | 16.28% | - |
As of 31 Dec 23, Agile Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 23 | 1 | - |
31 Mar, 22 | 16 | -27.27% |
31 Dec, 21 | 22 | 69.23% |
30 Sep, 21 | 13 | -60.61% |
30 Jun, 21 | 33 | - |
31 Mar, 21 | 33 | -13.16% |
31 Dec, 20 | 38 | 11.76% |
30 Sep, 20 | 34 | -44.26% |
30 Jun, 20 | 61 | 24.49% |
31 Mar, 20 | 49 | 25.64% |
31 Dec, 19 | 39 | 95.00% |
30 Sep, 19 | 20 | 122.22% |
30 Jun, 19 | 9 | -30.77% |
31 Mar, 19 | 13 | 30.00% |
31 Dec, 18 | 10 | -16.67% |
30 Sep, 18 | 12 | -25.00% |
30 Jun, 18 | 16 | -11.11% |
31 Mar, 18 | 18 | -45.45% |
31 Dec, 17 | 33 | 32.00% |
30 Sep, 17 | 25 | 25.00% |
30 Jun, 17 | 20 | -25.93% |
31 Mar, 17 | 27 | -18.18% |
31 Dec, 16 | 33 | 37.50% |
30 Sep, 16 | 24 | -20.00% |
30 Jun, 16 | 30 | -9.09% |
31 Mar, 16 | 33 | 73.68% |
31 Dec, 15 | 19 | -9.52% |
30 Sep, 15 | 21 | -44.74% |
30 Jun, 15 | 38 | 22.58% |
31 Mar, 15 | 31 | 181.82% |
31 Dec, 14 | 11 | -15.38% |
30 Sep, 14 | 13 | -35.00% |
30 Jun, 14 | 20 | - |
1 institutional shareholders have increased their position in AGRX stock as of 31 Dec 23 compared to 16 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 23 | - | - |
31 Mar, 22 | 7 | -46.15% |
31 Dec, 21 | 13 | -40.91% |
30 Sep, 21 | 22 | -12.00% |
30 Jun, 21 | 25 | - |
31 Mar, 21 | 25 | 38.89% |
31 Dec, 20 | 18 | -41.94% |
30 Sep, 20 | 31 | 244.44% |
30 Jun, 20 | 9 | -10.00% |
31 Mar, 20 | 10 | 66.67% |
31 Dec, 19 | 6 | 20.00% |
30 Sep, 19 | 5 | 66.67% |
30 Jun, 19 | 3 | -57.14% |
31 Mar, 19 | 7 | - |
31 Dec, 18 | 7 | 16.67% |
30 Sep, 18 | 6 | -33.33% |
30 Jun, 18 | 9 | -47.06% |
31 Mar, 18 | 17 | 88.89% |
31 Dec, 17 | 9 | -10.00% |
30 Sep, 17 | 10 | -37.50% |
30 Jun, 17 | 16 | 45.45% |
31 Mar, 17 | 11 | -26.67% |
31 Dec, 16 | 15 | 7.14% |
30 Sep, 16 | 14 | -12.50% |
30 Jun, 16 | 16 | 77.78% |
31 Mar, 16 | 9 | -35.71% |
31 Dec, 15 | 14 | 7.69% |
30 Sep, 15 | 13 | 18.18% |
30 Jun, 15 | 11 | 266.67% |
31 Mar, 15 | 3 | -25.00% |
31 Dec, 14 | 4 | -33.33% |
30 Sep, 14 | 6 | - |
30 Jun, 14 | - | - |
- institutional shareholders have reduced their position in AGRX stock as of 31 Dec 23 compared to 7 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 23 | 1 | - | 10 | - | 0.00% | - | 1 | - | - | - |
31 Mar, 22 | 35 | -25.53% | 40,559,779 | 7.73% | 32.55% | 2.16% | 16 | -27.27% | 7 | -46.15% |
31 Dec, 21 | 47 | -12.96% | 37,651,153 | 18.45% | 38.79% | 3.62% | 22 | 69.23% | 13 | -40.91% |
30 Sep, 21 | 54 | -25.00% | 31,787,149 | -7.56% | 32.75% | 1.99% | 13 | -60.61% | 22 | -12.00% |
30 Jun, 21 | 72 | -10.00% | 34,385,876 | -10.17% | 40.61% | 1.99% | 33 | - | 25 | - |
31 Mar, 21 | 80 | -5.88% | 38,279,166 | -5.42% | 45.20% | 1.98% | 33 | -13.16% | 25 | 38.89% |
31 Dec, 20 | 85 | -1.16% | 40,473,649 | 4.16% | 47.79% | 2.27% | 38 | 11.76% | 18 | -41.94% |
30 Sep, 20 | 86 | 1.18% | 38,855,790 | 0.98% | 45.88% | 0.76% | 34 | -44.26% | 31 | 244.44% |
30 Jun, 20 | 85 | 21.43% | 38,478,555 | 16.51% | 77.84% | 1.74% | 61 | 24.49% | 9 | -10.00% |
31 Mar, 20 | 70 | 32.08% | 33,025,635 | 21.30% | 66.81% | 2.20% | 49 | 25.64% | 10 | 66.67% |
31 Dec, 19 | 53 | 55.88% | 27,226,133 | 13.28% | 55.08% | 2.33% | 39 | 95.00% | 6 | 20.00% |
30 Sep, 19 | 34 | 25.93% | 24,033,991 | 22.75% | 48.62% | 3.10% | 20 | 122.22% | 5 | 66.67% |
30 Jun, 19 | 27 | -3.57% | 19,579,798 | 5.62% | 39.61% | 2.82% | 9 | -30.77% | 3 | -57.14% |
31 Mar, 19 | 28 | 3.70% | 18,538,164 | 96.54% | 37.50% | 10.30% | 13 | 30.00% | 7 | - |
31 Dec, 18 | 27 | -3.57% | 9,432,299 | -34.68% | 19.08% | 2.24% | 10 | -16.67% | 7 | 16.67% |
30 Sep, 18 | 28 | -26.32% | 14,440,164 | -19.21% | 29.21% | 2.23% | 12 | -25.00% | 6 | -33.33% |
30 Jun, 18 | 38 | -20.83% | 17,872,674 | -27.60% | 36.16% | 1.45% | 16 | -11.11% | 9 | -47.06% |
31 Mar, 18 | 48 | -7.69% | 24,685,305 | 1.42% | 49.94% | 2.06% | 18 | -45.45% | 17 | 88.89% |
31 Dec, 17 | 52 | 6.12% | 24,338,567 | -2.35% | 49.24% | 1.94% | 33 | 32.00% | 9 | -10.00% |
30 Sep, 17 | 49 | 8.89% | 24,925,236 | 8.02% | 50.42% | 2.31% | 25 | 25.00% | 10 | -37.50% |
30 Jun, 17 | 45 | -13.46% | 23,075,553 | 0.52% | 46.68% | 2.16% | 20 | -25.93% | 16 | 45.45% |
31 Mar, 17 | 52 | -21.21% | 22,957,028 | -1.96% | 46.44% | 2.07% | 27 | -18.18% | 11 | -26.67% |
31 Dec, 16 | 66 | 13.79% | 23,414,959 | -2.47% | 47.37% | 2.01% | 33 | 37.50% | 15 | 7.14% |
30 Sep, 16 | 58 | 1.75% | 24,007,669 | -0.75% | 48.57% | 2.03% | 24 | -20.00% | 14 | -12.50% |
30 Jun, 16 | 57 | 7.55% | 24,188,418 | -0.81% | 48.93% | 2.01% | 30 | -9.09% | 16 | 77.78% |
31 Mar, 16 | 53 | 8.16% | 24,385,433 | 47.39% | 49.33% | 4.40% | 33 | 73.68% | 9 | -35.71% |
31 Dec, 15 | 49 | - | 16,544,352 | -22.79% | 33.47% | 1.78% | 19 | -9.52% | 14 | 7.69% |
30 Sep, 15 | 49 | -14.04% | 21,428,616 | 24.98% | 43.35% | 3.60% | 21 | -44.74% | 13 | 18.18% |
30 Jun, 15 | 57 | 46.15% | 17,145,049 | 3.51% | 34.68% | 3.09% | 38 | 22.58% | 11 | 266.67% |
31 Mar, 15 | 39 | 77.27% | 16,563,019 | 27.00% | 33.51% | 4.81% | 31 | 181.82% | 3 | -25.00% |
31 Dec, 14 | 22 | -4.35% | 13,041,523 | 68.86% | 26.38% | 10.81% | 11 | -15.38% | 4 | -33.33% |
30 Sep, 14 | 23 | 15.00% | 7,723,423 | -4.03% | 15.62% | 5.90% | 13 | -35.00% | 6 | - |
30 Jun, 14 | 20 | - | 8,047,341 | - | 16.28% | - | 20 | - | - | - |
Agile Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Agile Therapeutics's stock was made by Coiante Scott M on Aug 25 2023, selling - shares at - per share (valued at -).
Agile Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2023 | 1 | - | - |
Q3 2023 | - | 1 | - |
Q2 2023 | 22 | - | - |
Q4 2022 | 6 | 1 | 600.00% |
Q3 2022 | 1 | - | - |
Q2 2022 | 7 | - | - |
Q1 2022 | 6 | - | - |
Q4 2021 | 8 | - | - |
Q3 2021 | 2 | - | - |
Q2 2021 | 14 | - | - |
Q1 2021 | 12 | 2 | 600.00% |
Q4 2020 | 1 | 1 | 100.00% |
Q3 2020 | 4 | 2 | 200.00% |
Q2 2020 | 13 | 1 | 1300.00% |
Q1 2020 | 17 | 1 | 1700.00% |
Q4 2019 | 4 | 2 | 200.00% |
Q3 2019 | 4 | - | - |
Q2 2019 | 7 | - | - |
Q1 2019 | 21 | 9 | 233.33% |
Q3 2018 | - | 1 | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Agile Therapeutics's insiders, as of Q4 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2023 | - | - | - |
Q3 2023 | - | - | - |
Q2 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | 1 | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 6 | - | - |
Q3 2021 | 2 | - | - |
Q2 2021 | 2 | - | - |
Q1 2021 | 4 | - | - |
Q4 2020 | - | - | - |
Q3 2020 | 1 | - | - |
Q2 2020 | - | - | - |
Q1 2020 | 5 | - | - |
Q4 2019 | 4 | 2 | 200.00% |
Q3 2019 | 1 | - | - |
Q2 2019 | 1 | - | - |
Q1 2019 | 3 | - | - |
Q3 2018 | - | 1 | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Agile Therapeutics's stocks.
Agile Therapeutics Peer Ownership
Ticker | Company |
---|---|
EVOK | Evoke Pharma, Inc. |
TKNO | Alpha Teknova, Inc. |
AMRX | Amneal Pharmaceuticals, Inc. |
AQST | Aquestive Therapeutics, Inc. |
LFCR | Lifecore Biomedical, Inc. |
GHSI | Guardion Health Sciences, Inc. |
ASRT | Assertio Holdings, Inc. |
SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
ACRX | Talphera, Inc. |
PTPI | Petros Pharmaceuticals, Inc. |
CPIX | Cumberland Pharmaceuticals Inc. |
CYTH | Cyclo Therapeutics, Inc. |
PRFX | PainReform Ltd. |
AGRX Ownership FAQ
Who Owns Agile Therapeutics?
Agile Therapeutics is owned by institutional shareholders (0.00%), insiders (9.70%), and public (90.30%). The largest institutional shareholder of Agile Therapeutics is CORNERSTONE PLANNING GROUP LLC (0% of total shares) and the top mutual fund owner is ROYCE MICRO-CAP TRUST, INC. (0.19% of total shares).
Who are the major institutional shareholders of Agile Therapeutics?
Agile Therapeutics's major institutional shareholders are CORNERSTONE PLANNING GROUP LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Agile Therapeutics shareholders are there?
As of Dec 2023, there are 1 institutional shareholders of Agile Therapeutics.
What percentage of Agile Therapeutics is owned by CORNERSTONE PLANNING GROUP LLC?
CORNERSTONE PLANNING GROUP LLC owns 0 shares of Agile Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).